162 related articles for article (PubMed ID: 19786906)
1. Trends in disparities in receipt of adjuvant therapy for elderly stage III colon cancer patients: the role of the medical oncologist evaluation.
Davidoff AJ; Rapp T; Onukwugha E; Zuckerman IH; Hanna N; Pandya N; Mullins CD
Med Care; 2009 Dec; 47(12):1229-36. PubMed ID: 19786906
[TBL] [Abstract][Full Text] [Related]
2. Residual treatment disparities after oncology referral for rectal cancer.
Morris AM; Billingsley KG; Hayanga AJ; Matthews B; Baldwin LM; Birkmeyer JD
J Natl Cancer Inst; 2008 May; 100(10):738-44. PubMed ID: 18477800
[TBL] [Abstract][Full Text] [Related]
3. Race and Insurance Differences in the Receipt of Adjuvant Chemotherapy Among Patients With Stage III Colon Cancer.
Murphy CC; Harlan LC; Warren JL; Geiger AM
J Clin Oncol; 2015 Aug; 33(23):2530-6. PubMed ID: 26150445
[TBL] [Abstract][Full Text] [Related]
4. Explaining black-white differences in receipt of recommended colon cancer treatment.
Baldwin LM; Dobie SA; Billingsley K; Cai Y; Wright GE; Dominitz JA; Barlow W; Warren JL; Taplin SH
J Natl Cancer Inst; 2005 Aug; 97(16):1211-20. PubMed ID: 16106026
[TBL] [Abstract][Full Text] [Related]
5. Racial disparities in receipt and comparative effectiveness of oxaliplatin for stage III colon cancer in older adults.
Mack CD; Carpenter W; Meyer AM; Sanoff H; Stürmer T
Cancer; 2012 Jun; 118(11):2925-34. PubMed ID: 22072441
[TBL] [Abstract][Full Text] [Related]
6. Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.
Yothers G; Sargent DJ; Wolmark N; Goldberg RM; O'Connell MJ; Benedetti JK; Saltz LB; Dignam JJ; Blackstock AW;
J Natl Cancer Inst; 2011 Oct; 103(20):1498-506. PubMed ID: 21997132
[TBL] [Abstract][Full Text] [Related]
7. Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma.
Murphy MM; Simons JP; Ng SC; McDade TP; Smith JK; Shah SA; Zhou Z; Earle CC; Tseng JF
Ann Surg Oncol; 2009 Nov; 16(11):2968-77. PubMed ID: 19669839
[TBL] [Abstract][Full Text] [Related]
8. Race and sex differences in the receipt of timely and appropriate lung cancer treatment.
Shugarman LR; Mack K; Sorbero ME; Tian H; Jain AK; Ashwood JS; Asch SM
Med Care; 2009 Jul; 47(7):774-81. PubMed ID: 19536007
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation.
Jessup JM; Stewart A; Greene FL; Minsky BD
JAMA; 2005 Dec; 294(21):2703-11. PubMed ID: 16333005
[TBL] [Abstract][Full Text] [Related]
10. Provider-based research networks may improve early access to innovative colon cancer treatment for African Americans treated in the community.
Penn DC; Chang Y; Meyer AM; DeFilippo Mack C; Sanoff HK; Stitzenberg KB; Carpenter WR
Cancer; 2015 Jan; 121(1):93-101. PubMed ID: 25209056
[TBL] [Abstract][Full Text] [Related]
11. Disparities in Use of Human Epidermal Growth Hormone Receptor 2-Targeted Therapy for Early-Stage Breast Cancer.
Reeder-Hayes K; Peacock Hinton S; Meng K; Carey LA; Dusetzina SB
J Clin Oncol; 2016 Jun; 34(17):2003-9. PubMed ID: 27069085
[TBL] [Abstract][Full Text] [Related]
12. Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study.
Lai Y; Wang C; Civan JM; Palazzo JP; Ye Z; Hyslop T; Lin J; Myers RE; Li B; Jiang B; Sama A; Xing J; Yang H
Gastroenterology; 2016 May; 150(5):1135-1146. PubMed ID: 26836586
[TBL] [Abstract][Full Text] [Related]
13. Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study.
Felix AS; Cohn DE; Brasky TM; Zaino R; Park K; Mutch DG; Creasman WT; Thaker PH; Walker JL; Moore RG; Lele SB; Guntupalli SR; Downs LS; Nagel CI; Boggess JF; Pearl ML; Ioffe OB; Randall ME; Brinton LA
Am J Obstet Gynecol; 2018 Nov; 219(5):459.e1-459.e11. PubMed ID: 30096321
[TBL] [Abstract][Full Text] [Related]
14. Examining potential colorectal cancer care disparities in the Veterans Affairs health care system.
Zullig LL; Carpenter WR; Provenzale D; Weinberger M; Reeve BB; Jackson GL
J Clin Oncol; 2013 Oct; 31(28):3579-84. PubMed ID: 24002515
[TBL] [Abstract][Full Text] [Related]
15. Geographic variation and sociodemographic disparity in the use of oxaliplatin-containing chemotherapy in patients with stage III colon cancer.
Panchal JM; Lairson DR; Chan W; Du XL
Clin Colorectal Cancer; 2013 Jun; 12(2):113-21. PubMed ID: 23137529
[TBL] [Abstract][Full Text] [Related]
16. Racial disparity in consultation, treatment, and the impact on survival in metastatic colorectal cancer.
Simpson DR; Martínez ME; Gupta S; Hattangadi-Gluth J; Mell LK; Heestand G; Fanta P; Ramamoorthy S; Le QT; Murphy JD
J Natl Cancer Inst; 2013 Dec; 105(23):1814-20. PubMed ID: 24231453
[TBL] [Abstract][Full Text] [Related]
17. Impact of race/ethnicity and socioeconomic status on adjuvant chemotherapy use among elderly patients with stage III colon cancer.
Hsieh MC; Chiu YW; Velasco C; Wu XC; O'Flarity MB; Chen VW
J Registry Manag; 2013; 40(4):180-7. PubMed ID: 24625772
[TBL] [Abstract][Full Text] [Related]
18. A tracking and feedback registry to reduce racial disparities in breast cancer care.
Bickell NA; Shastri K; Fei K; Oluwole S; Godfrey H; Hiotis K; Srinivasan A; Guth AA
J Natl Cancer Inst; 2008 Dec; 100(23):1717-23. PubMed ID: 19033569
[TBL] [Abstract][Full Text] [Related]
19. Racial disparities in treatment and survival of male breast cancer.
Crew KD; Neugut AI; Wang X; Jacobson JS; Grann VR; Raptis G; Hershman DL
J Clin Oncol; 2007 Mar; 25(9):1089-98. PubMed ID: 17369572
[TBL] [Abstract][Full Text] [Related]
20. Racial Disparities in the Receipt of Guideline Care and Cancer Deaths for Women with Ovarian Cancer.
Cronin KA; Howlader N; Stevens JL; Trimble EL; Harlan LC; Warren JL
Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):539-545. PubMed ID: 30487136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
